On-Demand Webinar

IND 申报提速秘诀：How to Expedite IND Filing with a Subscription Model

When choosing how to accomplish your IND submission, there can be many elements to the…

Certara2024 年 2 月 13 日

Conference

The 15th Japan Safety Pharmacology Society

Certara2024 年 2 月 13 日

Brochure

ToxStudio®: Secondary Intelligence™ 常见问题解答

Certara2024 年 2 月 9 日

Video

D360 Scientific Informatics Discovery Platform: User Stories

Transcript: I've joined companies both blueprint medicines and score therapeutics is one of the first…

Certara2024 年 2 月 8 日

Press Coverage

Upping the Ante for Predicting the Success of Alzheimer Disease Treatments

By Hugo Geerts, PhD, Piet van der Graaf, PharmD, PhD Over the past 20 years,…

Certara2024 年 2 月 8 日

Conference

Clinical Data Disclosure, Transparency & Plain Language Summaries 2024

Certara2024 年 2 月 7 日

Conference

DIA MASC

Certara2024 年 2 月 2 日

On-Demand Webinar

Drug Development’s New Model: Biosimulation from Discovery to Label Expansion

Key Highlights: How predictive technologies reshape drug development, mitigating project risks, navigating novel biomarkers, predicting…

Certara2024 年 2 月 2 日

Press Release

Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference

PRINCETON, N.J., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. （纳斯达克股票代码：CERT), a global leader…

Certara2024 年 2 月 1 日

On-Demand Webinar

驾驭“专利悬崖”：针对失去独占性和成熟产品的全方位渠道战略

Join us to understand the dynamics of the pharmaceutical market and learn how to maintain…

Certara2024 年 1 月 24 日

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

pre-update

IND 申报提速秘诀：How to Expedite IND Filing with a Subscription Model

The 15th Japan Safety Pharmacology Society

ToxStudio®: Secondary Intelligence™ 常见问题解答

D360 Scientific Informatics Discovery Platform: User Stories

Upping the Ante for Predicting the Success of Alzheimer Disease Treatments

Clinical Data Disclosure, Transparency & Plain Language Summaries 2024

DIA MASC

Drug Development’s New Model: Biosimulation from Discovery to Label Expansion

Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference

驾驭“专利悬崖”：针对失去独占性和成熟产品的全方位渠道战略

订阅时事通讯

快捷链接

解决方案

联系我们